Bellerophon Therapeutics, Inc. Gains 168.37%

Tue, Feb 18, 2020 at 05:30 PM

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) shot up at $9.21, a gain of 168.4%. The stock appeared on our News Catalysts scanner on Tue 18 Feb 20 at 09:12 AM in the 'BIOTECH' category. From Mon 27 Jan 20, the stock recorded 14.29% Up Days and 26.67% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Top 10 Gainers:

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 168.37%
Wanda Sports Group Company Limited (WSG:NASDAQ), 45.48%
Brickell Biotech, Inc. (BBI:NASDAQ), 42.24%
Zovio Inc (ZVO:NASDAQ), 30.49%
Intelsat S.A. (I:NYSE), 25.81%
Legg Mason, Inc. (LM:NYSE), 24.41%
Lilis Energy, Inc. (LLEX:NYSEMKT), 23.93%
Senseonics Holdings, Inc. (SENS:NYSEMKT), 23.85%
InflaRx N.V. (IFRX:NASDAQ), 23.6%
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 22.67%